Interactions of the antimicrobial peptide nisin Z with conventional antibiotics and the use of nanostructured lipid carriers to enhance antimicrobial activity

International Journal of Pharmaceutics

Volumn 526, Issue 1-2, 2017, Pages 244-253

  Lewies, Angélique ^a   Wentzel, Johannes Frederik ^a   Jordaan, Anine ^a   Bezuidenhout, Carlos ^a   Du Plessis, Lissinda Hester ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Antibiotic combination therapy; Antimicrobial peptides (AMPs); Nanostructured lipid carriers (NLC); Nisin Z; Solid lipid nanoparticles (SLN); Topical application

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; COLISTIN; EDETIC ACID; GENTAMICIN; LIPID; MELITTIN; METICILLIN; NANOCARRIER; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; NISIN; NISIN Z; NOVOBIOCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; DRUG CARRIER;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; PH; PRIORITY JOURNAL; PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ANALOGS AND DERIVATIVES; CHEMISTRY;

ANTI-BACTERIAL AGENTS; DRUG CARRIERS; LIPIDS; MELITTEN; NANOPARTICLES; NISIN; STAPHYLOCOCCUS AUREUS;

EID: 85019072424     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.04.071     Document Type: Article

References (55)

1. Abbaszadegan, A., Ghahramani, Y., Gholami, A., Hemmateenejad, B., Dorostkar, S., Nabavizadeh, M., Sharghi, H., The effect of charge at the surface of silver nanoparticles on antimicrobial activity against gram-positive and gram-negative bacteria: a preliminary study. J. Nanomater., 2015, 2015, 8.
2. Ayliffe, G.A., Green, W., Livingston, R., Lowbury, E.J., Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards. J. Clin. Pathol. 30 (1977), 40–44.
3. Bartoloni, A., Mantella, A., Goldstein, B.P., Dei, R., Benedetti, M., Sbaragli, S., Paradisi, F., In-vitro activity of nisin against clinical isolates of Clostridium difficile. J. Chemother. 16 (2004), 119–121.
4. Baym, M., Lieberman, T.D., Kelsic, E.D., Chait, R., Gross, R., Yelin, I., Kishony, R., Spatiotemporal microbial evolution on antibiotic landscapes. Science 353 (2016), 1147–1151.
5. Bernfield, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J., Zako, M., Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem 68 (1999), 729–777.
6. Brooks, B.D., Brooks, A.E., Therapeutic strategies to combat antibiotic resistance. Adv. Drug Deliv. Rev. 78 (2014), 14–27.
7. Burianek, L.L., Yousef, A.E., Solvent extraction of bacteriocins from liquid cultures. Lett. Appl. Microbiol. 31 (2000), 193–197.
8. CLSI, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition. CLSI document M07-A9. 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
9. Cao, L.T., Wu, J.Q., Xie, F., Hu, S.H., Mo, Y., Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J. Dairy Sci. 90 (2007), 3980–3985.
10. Carmona-Ribeiro, A.M., de Melo Carrasco, L.D., Novel formulations for antimicrobial peptides. Int. J. Mol. Sci. 15 (2014), 18040–18083.
11. Cleveland, J., Montville, T.J., Nes, I.F., Chikindas, M.L., Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 71 (2001), 1–20.
12. Dempsey, C.E., The actions of melittin on membranes. Biochim. Biophys. Acta 1031 (1990), 143–161.
13. de Villiers, M.M., Otto, D.P., Strydom, S.J., Lvov, Y.M., Introduction to nanocoatings produced by layer-by-layer (LbL) self-assembly. Adv. Drug Deliv. Rev. 63 (2011), 701–715.
14. de Vos, W.M., Mulders, J.W., Siezen, R.J., Hugenholtz, J., Kuipers, O.P., Properties of nisin Z and distribution of its gene, nisZ, in Lactococcus lactis. Appl. Environ. Microbiol. 59 (1993), 213–218.
15. Dosler, S., Gerceker, A.A., In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Chemotherapy 57 (2011), 511–516.
16. Elnaggar, Y.S., El-Massik, M.A., Abdallah, O.Y., Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int. J. Nanomed. 6 (2011), 3195–3205.
17. Fernandez, L., Delgado, S., Herrero, H., Maldonado, A., Rodriguez, J.M., The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation. J. Hum. Lact. 24 (2008), 311–316.
18. Fox, J.L., Antimicrobial peptides stage a comeback. Nat. Biotechnol. 31 (2013), 379–382.
19. Garcı́a-Fuentes, M., Torres, D., Alonso, M.J., Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf. B: Biointerfaces 27 (2003), 159–168.
20. Garcia-Orue, I., Gainza, G., Girbau, C., Alonso, R., Aguirre, J.J., Pedraz, J.L., Igartua, M., Hernandez, R.M., LL37 loaded nanostructured lipid carriers (NLC): a new strategy for the topical treatment of chronic wounds. Eur. J. Pharm. Biopharm. 108 (2016), 310–316.
21. Hancock, R.E., Diamond, G., The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8 (2000), 402–410.
22. He, J., Starr, C.G., Wimley, W.C., A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics. Biochim. Biophys. Acta 1848 (2015), 8–15.
23. Helander, I.M., Mattila-Sandholm, T., Permeability barrier of the Gram-negative bacterial outer membrane with special reference to nisin. Int. J. Food Microbiol. 60 (2000), 153–161.
24. Hommoss, A., Preservative system development for argan oil-loaded nanostructured lipid carriers. Die Pharm. 66 (2011), 187–191.
25. Hua, S., Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery. Int. J. Nanomed. 9 (2014), 735–744.
26. Ibrahim, W.M., AlOmrani, A.H., Yassin, A.E., Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability. Int. J. Nanomed. 9 (2014), 129–144.
27. Kaszuba, M., Corbett, J., Watson, F.M., Jones, A., High-concentration zeta potential measurements using light-scattering techniques. Philos. Trans. Ser. A Math. Phys. Eng. Sci. 368 (2010), 4439–4451.
28. Keck, C.M., Muller, R.H., Nanotoxicological classification system (NCS)—a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. Eur. J. Pharm. Biopharm. 84 (2013), 445–448.
29. Kopermsub, P., Mayen, V., Warin, C., Potential use of niosomes for encapsulation of nisin and EDTA and their antibacterial activity enhancement. Food Res. Int. 44 (2011), 605–612.
30. Lebeaux, D., Leflon-Guibout, V., Ghigo, J.M., Beloin, C., In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. J. Antimicrob. Chemother. 70 (2015), 1704–1712.
31. Lewies, A., Wentzel, J.F., Jacobs, G., Du Plessis, L.H., The potential use of natural and structural analogues of antimicrobial peptides in the fight against neglected tropical diseases. Molecules 20 (2015), 15392–15433.
32. Müller, R.H., Alexiev, U., Sinambela, P., Keck, C.M., Nanostructured lipid carriers (NLC): the second generation of solid lipid nanoparticles. Dragicevic, N., Maibach, H.I., (eds.) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, 2016, Springer Berlin Heidelberg, Berlin, Heidelberg, 161–185.
33. Malekinejad, H., Tukmechi, A., Ebrahimi, H., Bazargani-Gilani, B., One step forward to improve the latest method of antibacterial susceptibility testing of vitro-cultured bacteria: an implication for antibacterial efficacy of Enrofloxacine on Aeromonas hydrophila. World J. Microbiol. Biotechnol. 27 (2011), 147–151.
34. Marquele-Oliveira, F., de Almeida Santana, D.C., Taveira, S.F., Vermeulen, D.M., Moraes de Oliveira, A.R., da Silva, R.S., Lopez, R.F.V., Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation. J. Pharm. Biomed. Anal. 53 (2010), 843–851.
35. Marr, A.K., Gooderham, W.J., Hancock, R.E.W., Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6 (2006), 468–472.
36. Martins, S., Sarmento, B., Ferreira, D.C., Souto, E.B., Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoparticles. Int. J. Nanomed. 2 (2007), 595–607.
37. Mataraci, E., Dosler, S., In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 56 (2012), 6366–6371.
38. McAuliffe, O., Ross, R.P., Hill, C., Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev. 25 (2001), 285–308.
39. Morton, R.E., Evans, T.A., Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content. Anal. Biochem. 204 (1992), 332–334.
40. Mulders, J.W., Boerrigter, I.J., Rollema, H.S., Siezen, R.J., de Vos, W.M., Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur. J. Biochem. 201 (1991), 581–584.
41. Naghmouchi, K., Le Lay, C., Baah, J., Drider, D., Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res. Microbiol. 163 (2012), 101–108.
42. Natrajan, N., Sheldon, B.W., Efficacy of nisin-coated polymer films to inactivate Salmonella Typhimurium on fresh broiler skin. J. Food Prot. 63 (2000), 1189–1196.
43. Odds, F.C., Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother., 52, 2003, 1.
44. Peschel, A., Sahl, H.G., The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4 (2006), 529–536.
45. Prombutara, P., Kulwatthanasal, Y., Supaka, N., Sramala, I., Chareonpornwattana, S., Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity. Food Control 24 (2012), 184–190.
46. Reynolds, E.S., The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 17 (1963), 208–212.
47. Scherer, K.M., Spille, J.H., Sahl, H.G., Grein, F., Kubitscheck, U., The lantibiotic nisin induces lipid II aggregation, causing membrane instability and vesicle budding. Biophys. J. 108 (2015), 1114–1124.
48. Shimanovich, U., Gedanken, A., Nanotechnology solutions to restore antibiotic activity. J. Mater. Chem. B 4 (2016), 824–833.
49. Shin, J.M., Gwak, J.W., Kamarajan, P., Fenno, J.C., Rickard, A.H., Kapila, Y.L., Biomedical applications of nisin. J. Appl. Microbiol. 120 (2016), 1449–1465.
50. Siddiqui, A.R., Bernstein, J.M., Chronic wound infection: facts and controversies. Clin. Dermatol. 28 (2010), 519–526.
51. Tamma, P.D., Cosgrove, S.E., Maragakis, L.L., Combination therapy for treatment of infections with gram-negative bacteria. Clin. Microbiol. Rev. 25 (2012), 450–470.
52. van Vuuren, S.F., Suliman, S., Viljoen, A.M., The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials. Lett. Appl. Microbiol. 48 (2009), 440–446.
53. van Vuuren, S.F., Nkwanyana, M.N., de Wet, H., Antimicrobial evaluation of plants used for the treatment of diarrhoea in a rural community in northern Maputaland, KwaZulu-Natal, South Africa. BMC Complement. Altern. Med., 15, 2015, 53.
54. Wang, G., Li, X., Wang, Z., APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 44 (2016), D1087–1093.
55. Wu, J., Hu, S., Cao, L., Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob. Agents Chemother. 51 (2007), 3131–3135.